Close Menu

People with sickle cell disease are hopeful that the gene-editing tool CRISPR might be able to offer them relief, Technology Review reports.

"Patients are very intrigued by [CRISPR]. They think it sounds wonderful," Biree Andemariam, director of the New England Sickle Cell Institute at the University of Connecticut Health Center, tells Tech Review.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Newsweek discusses the privacy issues raised by digital medicine.

A group of statisticians wants to eliminate researchers' reliance on 'statistical significance,' according to NPR.

In Nature this week: genetic analysis of Anatolian farmers, cotton genome analysis, and more.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.